Barinthus Biotherapeutics plc. Quarterly Nonoperating Income (Expense) in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Barinthus Biotherapeutics plc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q3 2024.
  • Barinthus Biotherapeutics plc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.25M, a 10.3% decline year-over-year.
  • Barinthus Biotherapeutics plc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $5.82M, a 22.4% decline year-over-year.
  • Barinthus Biotherapeutics plc. annual Nonoperating Income (Expense) for 2023 was $7.39M, a 51.1% increase from 2022.
  • Barinthus Biotherapeutics plc. annual Nonoperating Income (Expense) for 2022 was $4.89M.
  • Barinthus Biotherapeutics plc. annual Nonoperating Income (Expense) for 2021 was -$5.92M, a 368% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $5.82M $1.25M -$144K -10.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $5.96M $1.34M -$41K -2.98% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $6M $1.36M -$1.39M -50.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $7.39M $1.88M -$106K -5.34% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 $7.5M $1.39M +$1.08M +348% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $6.42M $1.38M -$162K -10.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $6.58M $2.75M +$1.69M +160% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $4.89M $1.98M +$455K +29.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 $4.44M $311K -$648K -67.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $5.08M $1.54M +$667K +76.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $4.42M $1.06M +$10.3M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$5.92M $1.53M +$2.33M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 -$8.25M $959K -$669K -41.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$7.58M $872K +$193K +28.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$7.77M -$9.28M -$9.98M -1429% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $2.21M -$797K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 $1.63M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $679K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $698K Jan 1, 2020 Mar 31, 2020 10-Q 2021-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.